Skip to main content

Table 5 Comparison between patients administered different drugs for MS regarding BDNF level

From: Serum level of brain-derived neurotrophic factor in patients with relapsing–remitting multiple sclerosis: a potential biomarker for disease activity

Drugs

BDNF level (pg/ml) (remission group)

BDNF level (pg/ml) (relapse group)

Median

Q1

Q3

P value

Median

Q1

Q3

P value

Monthly methylprednisolone

220

175

245

0.617

325

255

950

0.792

Intramuscular Interferon beta-1a

275

205

325

250

250

250

Subcutaneous Interferon beta-1b

265

205

325

268

245

1500

Subcutaneous interferon beta-1a

223

213

2613

2608

215

5000

  1. BDNF brain-derived neurotrophic factor